Bausch Health Companies Inc. (TSE:BHC – Get Free Report)’s share price was down 5.1% on Friday . The company traded as low as C$7.28 and last traded at C$7.58. Approximately 297,421 shares traded hands during mid-day trading, an increase of 2% from the average daily volume of 290,720 shares. The stock had previously closed at C$7.99.
Bausch Health Companies Stock Performance
The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. The firm has a market capitalization of C$1.97 billion, a PE ratio of -11.09, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. The firm’s 50 day moving average price is C$9.90 and its 200-day moving average price is C$10.80.
Bausch Health Companies Company Profile
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Recommended Stories
- Five stocks we like better than Bausch Health Companies
- The Role Economic Reports Play in a Successful Investment Strategy
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- How Can Investors Benefit From After-Hours Trading
- Disney 2025 Shareholders: Major Updates for Investors
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.
